Last reviewed: June 21, 2026

Last updated: June 21, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that activates hunger-suppressing pathways in the brain and improves how your body uses insulin. Originally approved for diabetes management, this medication has become recognized for its powerful effects on weight loss and metabolic health—with cardiovascular benefits observed in major clinical trials.

How Semaglutide Works in Your Body

Semaglutide mimics a natural hormone called GLP-1, which your intestines release after you eat. This hormone signals your brain that you are satisfied, slows how fast food leaves your stomach, and helps your pancreas release the right amount of insulin when blood sugar rises. By activating GLP-1 receptors, semaglutide creates a cascade of metabolic changes that reduce appetite and improve blood sugar stability.

The medication also affects how your body stores fat and uses energy at the cellular level. Research shows it can help reduce visceral fat—the dangerous fat stored around your organs—which is linked to metabolic disease and inflammation. This dual action on appetite and metabolism makes semaglutide effective for multiple health conditions beyond simple weight management.

Semaglutide for Type 2 Diabetes and Blood Sugar Control

Semaglutide was initially developed to help people with type 2 diabetes lower their blood glucose levels and reduce their risk of heart attack and stroke. Clinical trials showed that patients using semaglutide experienced significant reductions in HbA1c—a measure of average blood sugar over three months—compared to placebo. The medication helps your body's cells respond better to insulin and encourages the pancreas to release insulin only when needed.

For people with diabetes who struggle with weight gain from other medications or dietary challenges, semaglutide addresses both conditions at once. Studies have shown that participants lost an average of 5–10% of body weight while on semaglutide for diabetes, which itself reduces the strain on the pancreas and improves long-term blood sugar control. This makes it especially valuable for those seeking to reverse prediabetes or prevent type 2 diabetes development.

Weight Loss and Metabolic Health Benefits

Clinical trials specifically testing semaglutide for weight management found that participants lost an average of 15% of their starting body weight over 68 weeks—significantly more than those given placebo. This level of weight loss can reverse obesity-related conditions, lower blood pressure, and reduce inflammation throughout the body. The weight loss effect comes from sustained appetite reduction, increased feelings of fullness, and a shift in how your body processes hunger signals.

Beyond the number on the scale, weight loss achieved with semaglutide therapy often improves quality of life metrics that matter most: improved sleep, reduced joint pain, better mobility, and increased confidence. Because semaglutide slows stomach emptying and reduces cravings for high-calorie foods, many patients find it easier to maintain their weight loss compared to diet-only approaches. This sustained benefit helps break the cycle of yo-yo dieting that frustrates many people.

Cardiovascular Protection and Long-Term Health

A landmark clinical trial called SUSTAIN-6 found that semaglutide reduced the risk of heart attack, stroke, and cardiovascular death by 26% in people with type 2 diabetes and established heart disease. This cardiovascular benefit appears to come from multiple mechanisms: lower blood sugar, reduced blood pressure, decreased inflammation, and improved cholesterol profiles. These findings suggest semaglutide offers protection beyond what would be expected from weight loss alone.

The cardiovascular benefits are particularly important for people carrying extra weight around the abdomen, which increases heart disease risk even at lower overall body weights. By reducing visceral fat and improving metabolic markers like triglycerides and LDL cholesterol, semaglutide helps lower your long-term risk of major health events. PlexusDx patients can track these improvements over time to see how personalized semaglutide therapy supports their heart health and longevity.

Personalized Semaglutide Therapy with PlexusDx Genetic Testing

Individual responses to semaglutide vary based on genetic factors that influence how your body processes hunger signals, stores fat, and responds to GLP-1 receptor stimulation. PlexusDx offers the Precision Peptide Genetic Test, which analyzes your DNA for key variants in genes like GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313. This test maps 14 metabolic pathways and 49 peptides to predict how well you may respond to semaglutide and whether combination therapy might be more effective.

By understanding your genetic predispositions, PlexusDx clinicians can recommend whether compounded semaglutide injection, oral semaglutide, or a dual-compound approach like GLP-Squared fits your unique biology. The Precision Peptide Genetic Test costs only $99 as an add-on after your first month of treatment, making it an affordable way to optimize your personalized therapy from the start. This data-driven approach removes guesswork and helps you achieve better results faster.

PlexusDx Semaglutide: Accessible, Affordable, and Personalized

PlexusDx delivers compounded semaglutide injections from licensed 503A compounding pharmacies to all 50 states without requiring insurance or membership fees. The medication starts at $149 per month across all commitment tiers, with your dose able to increase as needed while your price remains flat. This transparent pricing model means you never worry about unexpected costs as your provider optimizes your treatment—your dose may need to go up, your price won't.

PlexusDx also accepts HSA and FSA funds, making semaglutide therapy even more affordable for eligible patients. All medications are compounded under strict pharmacy standards to ensure purity and potency, and you receive personalized support from PlexusDx clinicians who understand both the science of GLP-1 therapy and the practical challenges of sustainable weight loss. Whether you choose weekly semaglutide injections or prefer oral formulations, PlexusDx makes precision weight loss therapy accessible without the gatekeeping of traditional insurance.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is semaglutide only for people with diabetes?

No. While semaglutide was originally developed for type 2 diabetes, clinical trials have confirmed it is highly effective for weight loss and metabolic health in people without diabetes. PlexusDx offers semaglutide to candidates seeking weight management, improved blood sugar control, or cardiovascular protection, regardless of diabetes status. A PlexusDx clinician will review your health history to determine if semaglutide is appropriate for you.

How much weight can I expect to lose with semaglutide?

Clinical trials show participants lost an average of 15% of body weight over 68 weeks with semaglutide therapy. Individual results vary based on genetics, lifestyle, dose escalation, and how long you continue treatment. Your PlexusDx clinician can discuss realistic expectations based on your starting weight, health history, and genetic profile from the Precision Peptide Genetic Test.

How much does semaglutide cost at PlexusDx?

PlexusDx compounded semaglutide injections start at $149 per month, and this price remains flat regardless of your dose level. The medication is available from all 50 states without insurance, accepts HSA/FSA funds, and includes no membership fees. If you choose the Precision Peptide Genetic Test to personalize your therapy, it costs $99 as a one-time add-on after your first month.

What are the common side effects of semaglutide?

The most common side effects are mild gastrointestinal effects like nausea, vomiting, diarrhea, or constipation, which typically improve as your body adjusts over the first few weeks. Serious side effects are rare but can include pancreatitis or severe allergic reactions. PlexusDx clinicians monitor you regularly and provide guidance on managing side effects through dose adjustments, timing adjustments, and dietary changes.

What does the PlexusDx Precision Peptide Genetic Test tell me?

The test analyzes 14 metabolic pathways and 49 peptides to identify genetic variants affecting your hunger hormones, fat storage, and GLP-1 receptor response. Key variants like GLP1R rs6923761 and GIPR rs1800437 help predict whether you'll respond well to semaglutide alone or might benefit from combination therapy like GLP-Squared. This information helps PlexusDx clinicians personalize your dose, formulation, and medication choice for optimal results.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves